nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—HTR1D—GPCR downstream signaling—AKT1—ocular cancer	0.000287	0.000287	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—HRAS—ocular cancer	0.000284	0.000284	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CDKN1B—ocular cancer	0.000284	0.000284	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—AKT1—ocular cancer	0.000281	0.000281	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CDKN1B—ocular cancer	0.000279	0.000279	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CCND1—ocular cancer	0.000279	0.000279	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CCND1—ocular cancer	0.000278	0.000278	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CCND1—ocular cancer	0.000277	0.000277	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—AKT1—ocular cancer	0.000276	0.000276	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MDM2—ocular cancer	0.000275	0.000275	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GNAQ—ocular cancer	0.000274	0.000274	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MDM2—ocular cancer	0.000272	0.000272	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MDM2—ocular cancer	0.000272	0.000272	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—HRAS—ocular cancer	0.000271	0.000271	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CCND1—ocular cancer	0.000271	0.000271	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CDKN1A—ocular cancer	0.00027	0.00027	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CDKN1A—ocular cancer	0.000269	0.000269	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CDKN1A—ocular cancer	0.000268	0.000268	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CDKN1B—ocular cancer	0.000267	0.000267	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CCND1—ocular cancer	0.000267	0.000267	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—AKT1—ocular cancer	0.000266	0.000266	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—AKT1—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—AKT1—ocular cancer	0.000262	0.000262	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—AKT1—ocular cancer	0.000262	0.000262	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CDKN1A—ocular cancer	0.000262	0.000262	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—AKT1—ocular cancer	0.00026	0.00026	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CDKN1A—ocular cancer	0.000258	0.000258	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—EP300—ocular cancer	0.000257	0.000257	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—EP300—ocular cancer	0.000256	0.000256	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—HRAS—ocular cancer	0.000256	0.000256	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—AKT1—ocular cancer	0.000255	0.000255	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—EP300—ocular cancer	0.000255	0.000255	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CCND1—ocular cancer	0.000254	0.000254	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—HRAS—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—HRAS—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CDKN1B—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—AKT1—ocular cancer	0.000251	0.000251	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—EP300—ocular cancer	0.000249	0.000249	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—AKT1—ocular cancer	0.000249	0.000249	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CDKN1B—ocular cancer	0.000248	0.000248	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CDKN1B—ocular cancer	0.000248	0.000248	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MDM2—ocular cancer	0.000248	0.000248	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CDKN1A—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—AKT1—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—AKT1—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MDM2—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—EP300—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CCND1—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—AKT1—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—TP53—ocular cancer	0.000238	0.000238	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MDM2—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CCND1—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CCND1—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MDM2—ocular cancer	0.000236	0.000236	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—EP300—ocular cancer	0.000234	0.000234	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CDKN1A—ocular cancer	0.000232	0.000232	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—HRAS—ocular cancer	0.00023	0.00023	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MDM2—ocular cancer	0.000229	0.000229	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CDKN1A—ocular cancer	0.000229	0.000229	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CDKN1A—ocular cancer	0.000229	0.000229	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—HRAS—ocular cancer	0.000228	0.000228	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GNA11—ocular cancer	0.000228	0.000228	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—HRAS—ocular cancer	0.000228	0.000228	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CDKN1B—ocular cancer	0.000226	0.000226	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—AKT1—ocular cancer	0.000226	0.000226	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MDM2—ocular cancer	0.000226	0.000226	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CDKN1B—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—AKT1—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MYC—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MYC—ocular cancer	0.000223	0.000223	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TGFB1—ocular cancer	0.000223	0.000223	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—AKT1—ocular cancer	0.000223	0.000223	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—AKT1—ocular cancer	0.000223	0.000223	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TGFB1—ocular cancer	0.000223	0.000223	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MYC—ocular cancer	0.000222	0.000222	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—AKT1—ocular cancer	0.000222	0.000222	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TGFB1—ocular cancer	0.000221	0.000221	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000221	0.000221	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—EP300—ocular cancer	0.000221	0.000221	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—HRAS—ocular cancer	0.00022	0.00022	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—EP300—ocular cancer	0.00022	0.00022	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—HRAS—ocular cancer	0.000219	0.000219	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—EP300—ocular cancer	0.000218	0.000218	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—EP300—ocular cancer	0.000218	0.000218	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MYC—ocular cancer	0.000217	0.000217	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TGFB1—ocular cancer	0.000217	0.000217	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CDKN1B—ocular cancer	0.000216	0.000216	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CCND1—ocular cancer	0.000216	0.000216	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CDKN1B—ocular cancer	0.000215	0.000215	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—AKT1—ocular cancer	0.000214	0.000214	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MYC—ocular cancer	0.000214	0.000214	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CCND1—ocular cancer	0.000214	0.000214	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TGFB1—ocular cancer	0.000213	0.000213	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—HRAS—ocular cancer	0.000213	0.000213	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—AKT1—ocular cancer	0.000213	0.000213	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000212	0.000212	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—HRAS—ocular cancer	0.00021	0.00021	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CDKN1B—ocular cancer	0.000209	0.000209	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CDKN1A—ocular cancer	0.000209	0.000209	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MDM2—ocular cancer	0.000208	0.000208	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—AKT1—ocular cancer	0.000207	0.000207	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CDKN1A—ocular cancer	0.000207	0.000207	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CCND1—ocular cancer	0.000206	0.000206	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CDKN1B—ocular cancer	0.000206	0.000206	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CCND1—ocular cancer	0.000205	0.000205	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MDM2—ocular cancer	0.000205	0.000205	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MYC—ocular cancer	0.000204	0.000204	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—AKT1—ocular cancer	0.000204	0.000204	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TGFB1—ocular cancer	0.000204	0.000204	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—AKT1—ocular cancer	0.000203	0.000203	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—AKT1—ocular cancer	0.000201	0.000201	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—AKT1—ocular cancer	0.000201	0.000201	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MDM2—ocular cancer	0.0002	0.0002	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CCND1—ocular cancer	0.0002	0.0002	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CDKN1A—ocular cancer	0.0002	0.0002	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CDKN1A—ocular cancer	0.000199	0.000199	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EP300—ocular cancer	0.000199	0.000199	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EP300—ocular cancer	0.000197	0.000197	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CCND1—ocular cancer	0.000197	0.000197	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—AKT1—ocular cancer	0.000194	0.000194	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—AKT1—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—HRAS—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CDKN1A—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MYC—ocular cancer	0.000192	0.000192	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TGFB1—ocular cancer	0.000192	0.000192	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—HRAS—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CDKN1A—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EP300—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CDKN1B—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MYC—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MYC—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TGFB1—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TGFB1—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EP300—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—AKT1—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—AKT1—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CDKN1B—ocular cancer	0.000187	0.000187	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MDM2—ocular cancer	0.000186	0.000186	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—HRAS—ocular cancer	0.000186	0.000186	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—AKT1—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—AKT1—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EP300—ocular cancer	0.000184	0.000184	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—ocular cancer	0.000184	0.000184	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—ocular cancer	0.000183	0.000183	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CDKN1B—ocular cancer	0.000183	0.000183	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCND1—ocular cancer	0.000181	0.000181	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—AKT1—ocular cancer	0.000181	0.000181	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EP300—ocular cancer	0.000181	0.000181	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—EP300—ocular cancer	0.000179	0.000179	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—ocular cancer	0.000178	0.000178	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCND1—ocular cancer	0.000178	0.000178	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—HRAS—ocular cancer	0.000176	0.000176	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—ocular cancer	0.000176	0.000176	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—HRAS—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CDKN1A—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCND1—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—HRAS—ocular cancer	0.000174	0.000174	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MYC—ocular cancer	0.000173	0.000173	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—HRAS—ocular cancer	0.000173	0.000173	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TGFB1—ocular cancer	0.000173	0.000173	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CDKN1A—ocular cancer	0.000172	0.000172	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MYC—ocular cancer	0.000171	0.000171	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TGFB1—ocular cancer	0.000171	0.000171	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—HRAS—ocular cancer	0.000171	0.000171	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AKT1—ocular cancer	0.000171	0.000171	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CDKN1B—ocular cancer	0.00017	0.00017	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CDKN1A—ocular cancer	0.000169	0.000169	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AKT1—ocular cancer	0.000168	0.000168	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—HRAS—ocular cancer	0.000168	0.000168	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AKT1—ocular cancer	0.000168	0.000168	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—ocular cancer	0.000168	0.000168	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EP300—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MYC—ocular cancer	0.000166	0.000166	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TGFB1—ocular cancer	0.000165	0.000165	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MYC—ocular cancer	0.000165	0.000165	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AKT1—ocular cancer	0.000164	0.000164	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TGFB1—ocular cancer	0.000164	0.000164	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EP300—ocular cancer	0.000164	0.000164	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCND1—ocular cancer	0.000162	0.000162	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EP300—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—HRAS—ocular cancer	0.00016	0.00016	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MYC—ocular cancer	0.00016	0.00016	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TGFB1—ocular cancer	0.00016	0.00016	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—ocular cancer	0.000158	0.000158	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MYC—ocular cancer	0.000158	0.000158	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TGFB1—ocular cancer	0.000157	0.000157	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CDKN1A—ocular cancer	0.000157	0.000157	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—ocular cancer	0.000156	0.000156	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—ocular cancer	0.000156	0.000156	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AKT1—ocular cancer	0.000155	0.000155	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AKT1—ocular cancer	0.000155	0.000155	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AKT1—ocular cancer	0.000154	0.000154	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AKT1—ocular cancer	0.000153	0.000153	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—HRAS—ocular cancer	0.000151	0.000151	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AKT1—ocular cancer	0.000151	0.000151	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EP300—ocular cancer	0.000149	0.000149	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—HRAS—ocular cancer	0.000149	0.000149	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—HRAS—ocular cancer	0.000149	0.000149	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AKT1—ocular cancer	0.000148	0.000148	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MYC—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TGFB1—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MYC—ocular cancer	0.000143	0.000143	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TGFB1—ocular cancer	0.000143	0.000143	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—ocular cancer	0.000142	0.000142	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AKT1—ocular cancer	0.000142	0.000142	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—ocular cancer	0.000141	0.000141	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MYC—ocular cancer	0.00014	0.00014	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TGFB1—ocular cancer	0.00014	0.00014	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—HRAS—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—ocular cancer	0.000135	0.000135	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—HRAS—ocular cancer	0.000135	0.000135	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AKT1—ocular cancer	0.000133	0.000133	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—AKT1—ocular cancer	0.000133	0.000133	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AKT1—ocular cancer	0.000132	0.000132	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AKT1—ocular cancer	0.000132	0.000132	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—ocular cancer	0.000132	0.000132	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MYC—ocular cancer	0.00013	0.00013	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—HRAS—ocular cancer	0.00013	0.00013	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TGFB1—ocular cancer	0.00013	0.00013	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—ocular cancer	0.000129	0.000129	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—HRAS—ocular cancer	0.000129	0.000129	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—HRAS—ocular cancer	0.000126	0.000126	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—HRAS—ocular cancer	0.000124	0.000124	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—EP300—ocular cancer	0.000123	0.000123	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AKT1—ocular cancer	0.00012	0.00012	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—ocular cancer	0.000119	0.000119	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AKT1—ocular cancer	0.000119	0.000119	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—ocular cancer	0.000117	0.000117	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—ocular cancer	0.000115	0.000115	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AKT1—ocular cancer	0.000115	0.000115	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AKT1—ocular cancer	0.000114	0.000114	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—HRAS—ocular cancer	0.000114	0.000114	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—HRAS—ocular cancer	0.000112	0.000112	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AKT1—ocular cancer	0.000111	0.000111	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—HRAS—ocular cancer	0.00011	0.00011	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AKT1—ocular cancer	0.000109	0.000109	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—AKT1—ocular cancer	0.000108	0.000108	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—ocular cancer	0.000107	0.000107	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—HRAS—ocular cancer	0.000102	0.000102	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AKT1—ocular cancer	0.000101	0.000101	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AKT1—ocular cancer	9.92e-05	9.92e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—EP300—ocular cancer	9.86e-05	9.86e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AKT1—ocular cancer	9.71e-05	9.71e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AKT1—ocular cancer	9.02e-05	9.02e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—EP300—ocular cancer	7.61e-05	7.61e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AKT1—ocular cancer	7.46e-05	7.46e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AKT1—ocular cancer	5.96e-05	5.96e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AKT1—ocular cancer	4.6e-05	4.6e-05	CbGpPWpGaD
